HIV Demonstration, Research, Public and Professional Education Projects

Active

Assistance listing
93.941
Agency
Grant awards
294 $1,158,139,801 in federal obligations

Program facts

Assistance types
  • Cooperative Agreement
  • Block Grant
Treasury account
  • 75-0950-0-1-550
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The CDC's Centers for Disease Control and Prevention funds HIV prevention, treatment, care, and research demonstration projects under Assistance Listing 93.941, with the most recent grant award on June 1, 2024.

The program supports applied research and demonstration projects that develop, test, and disseminate HIV prevention strategies targeting hard-to-reach populations at risk. Recent awards fund behavioral and implementation science research addressing HIV prevention among racial and ethnic minorities disproportionately affected by the epidemic, including men who have sex with men, Black cisgender women, transgender women, people who inject drugs, and Latinx and Caribbean populations. Activities also include school-based adolescent sexual health and HIV/STD prevention programs, PrEP (pre-exposure prophylaxis) navigation and implementation in clinical and community settings, telehealth and data-to-care strategies for medication adherence and retention in HIV care, and research on novel biomedical HIV prevention tools. Projects run 1 to 5 years, with non-competitive continuation funding available after initial awards contingent on satisfactory progress.

The program has distributed $1.16 billion in combined federal obligated dollars across 294 awards since 2002. Cooperative Agreements dominate the funding mix at 59 percent of awards (174 grants), with Block Grants at 23 percent and Project Grants at 18 percent. The CDC's Division of HIV Prevention accounts for the overwhelming majority of awards and federal dollars obligated, concentrating funding in its strategic priorities around prevention implementation and research capacity in minority communities.

Recent award amounts range from under $500 thousand to roughly $5 million to $7.6 million for larger implementation research studies. Recent examples include five cooperative agreements issued June 1, 2024, totaling approximately $1.75 million to $2.1 million each, supporting PrEP uptake research among Black women, Latinx sexual and gender minorities, and implementation of oral and long-acting injectable PrEP services in federally qualified health centers. A September 2023 award of $5.86 million supported the Project PROVIDE study on PrEP optimization via implementation, dissemination, and evaluation.

Two opportunities are currently open. RFA-PS-24-063 (Minority HIV Research Initiative) closed January 16, 2024, and supports epidemiologic, behavioral, and implementation science research in racial/ethnic minority communities disproportionately affected by HIV aligned with the Ending the HIV Epidemic initiative. RFA-DP-24-138 (What Works in Schools), posted December 11, 2023, with an April 1, 2024, due date, funds school-based or school-linked demonstration projects addressing sexual and reproductive health, mental and behavioral health, suicidality, substance use, and violence among youth in rural or American Indian/Alaska Native communities.

Objective and description

Objective

To develop, test, and disseminate improved human immunodeficiency virus (HIV) prevention strategies.

Eligibility

Applicant eligibility

States, political subdivisions of States, other public including American Indian/Alaska Native tribal governments or tribal organizations located wholly or in part within their boundaries, and nonprofit private entities.

Beneficiary eligibility

States, political subdivisions of States, other public including American Indian/Alaska Native tribal governments or tribal organizations located wholly or in part within their boundaries, and nonprofit private entities.

Credentials and documentation

Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing.

Uses of assistance

To assist States, political subdivisions of States, and other public and nonprofit entities with research on the prevention of HIV infection at the community level. Funds may be used to develop, implement and evaluate new interventions, including those targeting people who are infected with HIV. Applicants are encouraged to have research groups participate in the program.

Length and time phasing of assistance

Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.

How to apply

Preapplication coordination

Any required coordination will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing.

Criteria for selecting proposals

Applications will be evaluated on the extent to which proposed objectives are specific, measurable, time-phased, and consistent with the stated purpose of this program; the extent to which the applicant's proposed plan will identify and reach appropriate hard-to-reach individuals at risk for HIV, and the quality and scope of the applicant's past and current activities to provide education about HIV prevention and AIDS to high risk individuals; the quality of the applicant's proposed interventions and strategies to motivate and reinforce risk reduction behavior change among hard-to-reach individuals; the quality of the applicant's proposed plan to promote changes in community norms regarding HIV prevention and risk reduction behavior, and to generate support, cooperation, and collaboration with community based organizations serving individuals at high risk for HIV; the extent to which the applicant's proposed plan will determine, monitor, and measure changes in the prevalence of specific knowledge, attitudes, beliefs and self-reported behaviors among hard-to-reach individuals; the quality of the applicant's plan, including proposed methods and instruments of measurement to evaluate effectiveness of the strategies used to motivate and reinforce behavior change among groups targeted by the interventions, and the impact of the programmatic efforts on community norms; the extent to which the applicant's proposed plan will enable it to respond to and redirect programmatic efforts based on new information, changes in behavior, and changes in HIV seroprevalence.

Award procedure

After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.

Deadlines

Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.

Renewals

Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.

Grant opportunities

Opportunity Status Posted Applications due
Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works in Schools Approach RFA-DP-24-138 Closed
Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers RFA-PS-24-063 Closed
Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works in Schools Approach RFA-PS-24-038 Past —
Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP) RFA-PS-23-001 Closed
Implementation Research on Telehealth Strategies to Support Retention in Care and Treatment among Antiretroviral Therapy (ART) Patients and Pre-exposure Prophylaxis (PrEP) Clients RFA-PS-22-002 Closed
Implementing Pre-exposure Prophylaxis for HIV Prevention in Syringe Service Programs RFA-PS-22-001 Closed
PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices RFA-PS-21-003 Closed
Implementation Research Consortium to Accelerate Impact of Health Department-Delivered HIV Prevention Activities RFA-PS-21-002 Closed
Implementing and Evaluating a Data-to-Care Rx Strategy RFA-PS-21-004 Closed
Minority HIV Research Initiative (MARI) to Support Epidemiologic and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers RFA-PS-21-001 Closed
Evaluation of New HIV Testing Technologies in Clinical Settings with High HIV Incidence RFA-PS-20-001 Closed
Strategies to Maintain HIV Viral Suppression Among State Prison Inmates Released to the Community CDC-RFA-PS20-2011 Closed
Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Researchers RFA-PS-16-00103CONT18 Closed
Data to Care Rx: Using Real-time Prescription Claims Data to Support the HIV Care Continuum CDC-RFA-PS17-1709 Closed
Centers for Disease Control and Prevention Increase Access to Care for Black Men Who Have Sex with Men RFA-PS-16-00402CONT17 Closed
Centers for Disease Control and Prevention Mobile Messaging Intervention to Present New HIV Prevention Options for MSM RFA-PS-15-00203CONT17 Closed
Centers for Disease Control and Prevention Positive Health Check Evaluation Trial Solicitation for FY2017 Noncompetitive Continuation Application RFA-PS-15-00103CONT17 Closed
Centers for Disease Control and Prevention Positive Health Check Evaluation Trial Solicitation for FY2017 Noncompetitive Continuation Application RFA-PS15-00103CONT Closed
Centers for Disease Control and Prevention Epicenters for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance, and Adverse Events RFA-CK-16-00402CONT17 Closed
Strengthening HIV/AIDS Research in Kenya RFA-PS-17-005 Closed
Evaluation of Models of PrEP Service Delivery at Title X and STD Clinics RFA-PS-17-004 Closed
Early HIV Treatment to Optimize Patient Health and HIV Prevention RFA-PS-16-006 Closed
Increase Access to Care for Black Men Who Have Sex with Men RFA-PS-16-004 Closed
A National Coalition to Enhance STD/HIV Prevention through Promotion of a Holistic Approach to Health and Wellness CDC-RFA-PS11-111205CONT15 Closed
Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Researchers RFA-PS-16-001 Closed
Positive Health Check Evaluation Trial RFA-PS-15-001 Closed
Mobile Messaging Intervention to Present New HIV Prevention RFA-PS-15-002 Closed
Communication and Technical Assistance Support for HIV/AIDS Prevention Programs, NCHHSTP/DHAP CDC-RFA-PS09-92104CONT12 Closed
Show all 28

Grant awards

Award Recipient Federal obligations Awarded
PS24-063, mari: epidemiologic, behavioral, and implementation science research in racial/ethnic minority communities… U01PS005284 The Johns Hopkins University $1,749,751
PS24-063, mari: integration of latino MSM-tailored oral and long-acting injectable prep services in federally qualified… U01PS005282 Emory University $2,099,990
PS24-063, mari: understanding medical mistrust to inform adaptation of an HIV prevention intervention for latinx sexual… U01PS005281 Northwestern University $1,749,930
PS24-063, mari project: salud movil: strengthening access in latinos using digital and mobile outreach through… U01PS005279 Emory University $1,749,999
PS24-063, mari: refining and pilot testing an intervention to improve prep uptake among marginalized black cisgender… U01PS005278 The Research Foundation For The State University Of New York $1,749,559
RFA-PS-23-001 - project provide: prep optimization via implementation, dissemination, and evaluation U01PS005270 ANN & Robert H Lurie Childrens Hospital Of Chicago $5,861,071
Using real-time prescription data to support HIV care and treatment adherence in NYC U01PS005221 Amida Care Inc. $4,598,602
Promoting prep adherence for men who have SEX with men of color: more options, less barriers U01PS005236 University Of North Carolina At Chapel Hill $1,272,341
Implementation of rapid HIV testing and linkage to HIV treatment or prevention among vulnerable populations in tennessee U01PS005240 Vanderbilt University Medical Center $6,289,608
Strategies to maintain HIV viral suppression among state prison inmates released to the community NU62PS924645 South Carolina Department Of Public Health $3,377,514

Latest 10 of 294 listed here. See the rest on GovTribe.

Top recipients by federal obligations

8 of 149 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $3,309,371
FY2025 $8,334,011
FY2024 $15,506,044
FY2023 $12,297,495
FY2022 $19,153,267
FY2021 $8,439,101
FY2020 $13,344,360
FY2019 $12,434,989
FY2018 $9,803,361
FY2017 $10,196,262
FY2016 $6,947,092
FY2015 $5,919,731
FY2014 $8,491,321
FY2013 $20,182,259
FY2012 $15,107,260
FY2011 $128,478,224
FY2010 $285,249,867
FY2009 $390,490,650
FY2008 $194,338,883
FY2007 $160,962,008
FY2006 -$7,825,910
FY2005 $636
FY2004 $1,975,502
FY2003 $249,686
FY2002 $1,241,393
Show all 25

Quick answers

What is Assistance Listing 93.941?

Assistance Listing 93.941 is HIV Demonstration, Research, Public and Professional Education Projects, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).

What is the CFDA number for HIV Demonstration, Research, Public and Professional Education Projects?

Its CFDA number is 93.941: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.941 awarded?

294 grant awards under 93.941 have obligated $1,158,139,801 in federal funds to 149 recipients.

Who receives the most funding from 93.941?

The recipients obligated the most under HIV Demonstration, Research, Public and Professional Education Projects are The Trustees Of Columbia University In The City Of New York ($375,168,142), Elizabeth Glaser Pediatric Aids Foundation ($304,867,648) and Emory University ($18,821,857).

How much did 93.941 obligate in fiscal year 2025?

Grants under 93.941 obligated $8,334,011 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.941?

No opportunity listed under 93.941 is open now. The latest, Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works in Schools Approach, was posted on December 11, 2023.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program